Lazard-backed SPACs aim to raise US$500m in IPOs
Bengaluru
TWO special purpose acquisition companies (SPACs) backed by investment bank Lazard are aiming to raise as much as US$500 million in initial public offerings, according to regulatory filings on Monday.
Lazard Healthcare Acquisition Corp I and Lazard Fintech Acquisition Corp I are looking to raise US$250 million each, saying they aim to merge with companies in the healthcare and fintech sectors, respectively.
In January, another SPAC backed by the investment bank said it aimed to raise US$500 million in a US IPO, with an eye on the healthcare, technology, energy transition, financial and consumer sectors.
SPACs are shell firms that have no business operations but are still listed. Their sole purpose is to use capital from an IPO to merge with a private firm, allowing them to go public with lesser regulatory scrutiny.
However, a surge in the number of such blank-cheque firms over the last year has prompted concerns of a bubble. The Defiance Next Gen SPAC Derived ETF, an exchange-traded fund (ETF) that tracks SPACs, fell 16 per cent from a year high in mid-February as of its last close.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Lazard Healthcare Acquisition Corp I and Lazard Fintech Acquisition Corp I's units will be listed on Nasdaq under the symbols "LHCAU" and "LFTAU", respectively.
Goldman Sachs is the sole underwriter for both offerings. REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Jim Beam owner bets on canned vodka cocktails to double revenue
Hot stock: Nio climbs about 19.8% on stronger vehicle delivery performance
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Hot stock: DBS hits all-time high on record Q1 net profit
Japanese companies struggle with yen’s continued weakness
Singapore stocks open stronger on Thursday; STI up 0.5%